Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
Analysts Expecting Higher Bids for Amylin (AMLN)
-
Notable 52-Week Highs and Lows of the Day 12/20: (CVS) (HD) (SBUX) High; (RIMM) (TRGT) Low
-
Piper Jaffray Initiates Coverage on Rigel Pharmaceuticals (RIGL) with an Overweight; Investor Apathy Creates Unique Opportunity
-
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Notable Analyst Rating Changes 11/09: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
-
Unusual 11 Mid-Day Movers 7/8: NVGN, GRVY, TRGT, AMGN Higher; ARYX, RODM, YRCW, GNW Lower
-
Morning Movers 7/8: TRGT, HNAB, AMGN, NTWK, FDO Higher; ARYX, XNPT, ARNA, AXL Lower
-
Notable Analyst Rating Changes 4/27: BUCY, JOYG, MMM, NFLX Upgraded; BNI, HON, MAR, SONC Downgraded
-
Amylin (AMLN) Tumbles as Competitor to Byetta, Novo Nordisk's liraglutide, Does Not Receive FDA Recommendation
-
Notable Analyst Rating Changes 1/30: TER, TRA, AZN, BSX Upgraded; X, ALL, SGP, UA Downgraded
-
David Moenning's Daily State of the Markets: 1/29
-
David Moenning's Daily State of the Markets: 4/18
-
Notable Analyst Rating Changes 4/8: UBS, FNM, FRE, PSUN Upgraded; AAPL, AZN, LIFC Downgraded
